{"id":"W1887821162","doi":"10.1016/j.jalz.2015.05.003","title":"The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans","year":2015,"lang":"en","type":"review","venue":"Alzheimer s & Dementia","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; National Science Foundation, United Arab Emirates; Genentech; IXICO; H. Lundbeck A/S; Servier; Eisai; National Institutes of Health; Ministry of Science, ICT and Future Planning; National Research Foundation; Northern California Institute for Research and Education; BioClinica; Biogen; Pfizer; Novartis Pharmaceuticals Corporation; University of Southern California; U.S. Department of Defense; Eli Lilly and Company; Bristol-Myers Squibb; University of California, San Diego; Alzheimer's Disease Neuroimaging Initiative; Medical Research Council; Meso Scale Diagnostics; Alzheimer's Association","keywords":"Biomarker; Alzheimer's Disease Neuroimaging Initiative; Biobank; Neuroimaging; Disease; Medicine; Amyloid beta; Oncology; Alzheimer's disease; Psychology; Neuroscience; Internal medicine; Bioinformatics; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001516989,0.0006402911,0.001724819,0.0002171872,0.0002177563,0.00008521169,0.0004112876,0.0001080268,0.0001673696],"category_scores_gemma":[0.0001859363,0.0003995022,0.0005217004,0.0005826928,0.0007928562,0.0001501236,0.0005045029,0.0004876022,0.0000676239],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001218765,"about_ca_system_score_gemma":0.001074455,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007653677,"about_ca_topic_score_gemma":0.000001720994,"domain_scores_codex":[0.9958342,0.0005562162,0.0011227,0.0007168534,0.001101619,0.0006684053],"domain_scores_gemma":[0.9969702,0.0003229734,0.0007017681,0.0007744692,0.0006267718,0.0006038076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007655221,0.000175655,0.00147248,0.0128352,0.02471919,0.0001731816,0.00001910078,6.352847e-10,9.629065e-8,0.00008656494,0.01263049,0.9478115],"study_design_scores_gemma":[0.0005170077,0.000187518,0.001382838,0.04024657,0.1718996,0.00007803097,0.00001753279,0.000006233433,0.000002246451,0.0000498211,0.7853152,0.0002973694],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002647947,0.9925035,0.000003933867,0.0006446117,0.0002078352,0.004368212,0.0002158993,0.00004595101,0.002007452],"genre_scores_gemma":[0.0003238997,0.9973824,0.000122387,0.0005590264,0.0001030673,0.0007803985,0.0006147168,0.00009760884,0.00001649429],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9475141,"threshold_uncertainty_score":0.9998457,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1427812303360423,"score_gpt":0.4158644802061593,"score_spread":0.273083249870117,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}